Published Date: 10 Mar 2023
United States: The US research team recommended using a different agent to enhance the Doppler profile for more accurate measurements.
Read Full NewsWomen living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...
1.
Including Bereavement in the Care Continuum.
2.
Patients with head and neck cancer who cannot receive cisplatin now have new hope.
3.
Glioblastoma cells can 'unstick' from their neighbors to become more deadly
4.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
5.
tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.
1.
Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration
2.
Treating Methemoglobinemia: What You Need to Know Now!
3.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
4.
Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care
5.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XV
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation